These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2979039)

  • 21. [Campylobacter pylori in endoscopic biopsies of the gastric antrum and its association with chronic gastritis].
    Ocaña Andrade E; Espinosa Soberanes JA; Marañón Sepúlveda M; Díaz Oyola M; Yañez Montes C
    Rev Gastroenterol Mex; 1989; 54(4):207-11. PubMed ID: 2616983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mono and dual therapy for Helicobacter pylori associated gastritis.
    Gill HH; Desai HG; Mehta PR; Ranganathan S; Kalro RH; Murti PK; Prabhu SR
    J Assoc Physicians India; 1991 Oct; 39(10):743-5. PubMed ID: 1816196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Campylobacter pylori. Diagnosis and treatment.
    Tytgat GN; Rauws EA; de Koster EH
    J Clin Gastroenterol; 1989; 11 Suppl 1():S49-53. PubMed ID: 2681390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A four-year follow-up of duodenal ulcer patients after Helicobacter pylori eradication.
    Tepes B; Kavcic B; Gubina M; Krizman I
    Hepatogastroenterology; 1999; 46(27):1746-50. PubMed ID: 10430336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of antibiotics in Campylobacter pylori associated peptic ulcer disease.
    Bayerdörffer E; Ottenjann R
    Scand J Gastroenterol Suppl; 1988; 142():93-100. PubMed ID: 3047854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of apoptosis and proliferation of epitheliocytes in morphogenesis of Helicobacter pylori-associated gastritis].
    Kogan EA; Bondarenko OIu; Sklianskaia OA; Lapina TL; Demura SA; Azov AG; Ivashkin VT
    Arkh Patol; 2003; 65(6):22-6. PubMed ID: 14964963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Campylobacter pylori-associated gastritis: a double-blind placebo-controlled trial with amoxycillin.
    Glupczynski Y; Burette A; Labbe M; Deprez C; De Reuck M; Deltenre M
    Am J Gastroenterol; 1988 Apr; 83(4):365-72. PubMed ID: 3279757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study.
    Kyzekova J; Mour J
    Hepatogastroenterology; 1999; 46(27):2048-56. PubMed ID: 10430396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of bismuth subsalicylate on the histologic gastritis seen with Campylobacter pylori: a placebo-controlled, randomized study.
    Lanza FL; Skoglund ML; Rack MF; Yardley JH
    Am J Gastroenterol; 1989 Sep; 84(9):1060-4. PubMed ID: 2773899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo susceptibility of Campylobacter pylori.
    Graham DY; Klein PD; Opekun AR; Smith KE; Polasani RR; Evans DJ; Evans DG; Alpert LC; Michaletz PA; Yoshimura HH
    Am J Gastroenterol; 1989 Mar; 84(3):233-8. PubMed ID: 2919580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of colloidal bismuth subcitrate in gastric ulcer and gastritis.
    Tytgat GN; Rauws E; Langenberg W
    Scand J Gastroenterol Suppl; 1986; 122():22-9. PubMed ID: 3535018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Electron microscopic findings during treatment of Campylobacter pylori-positive gastritis with bismuth salts].
    Rauws EA; Tytgat GN
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():41-3. PubMed ID: 3687150
    [No Abstract]   [Full Text] [Related]  

  • 33. Effective 2-wk therapy for Helicobacter pylori disease in children.
    Dohil R; Israel DM; Hassall E
    Am J Gastroenterol; 1997 Feb; 92(2):244-7. PubMed ID: 9040199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between Campylobacter pylori and gastritis in healthy humans after administration of placebo or indomethacin.
    Peterson WL; Lee E; Feldman M
    Gastroenterology; 1988 Nov; 95(5):1185-97. PubMed ID: 3169487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maintenance therapy with colloidal bismuth subcitrate reduces duodenal ulcer relapse.
    Bardhan KD; Singh S; Morris P; Thompson M; Hinchliffe RF; Cary BA; Wall RM; Blakemore CB
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):128-34. PubMed ID: 9646192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the effects of Helicobacter pylori eradication therapy on gastric antral epithelial hyperproliferation: a prospective six-month follow-up study.
    Demiray M; Gulten M; Manavoglu O; Evrensel T; Ulukaya E; Yerci O; Kanat O; Kurt E; Arslan M; Gonullu G; Demiray H; Gulten T; Memik F
    Hepatogastroenterology; 2004; 51(59):1531-5. PubMed ID: 15362794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of oral bismuth subsalicylate on Campylobacter pylori and on healing and relapse rate of peptic ulcer.
    Eberhardt R; Kasper G
    Rev Infect Dis; 1990; 12 Suppl 1():S115-9. PubMed ID: 2406852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation.
    Nakao K; Imoto I; Ikemura N; Shibata T; Takaji S; Taguchi Y; Misaki M; Yamauchi K; Yamazaki N
    Am J Gastroenterol; 1997 Jun; 92(6):1005-11. PubMed ID: 9177520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implications of corpus gastritis, atrophy and cyclooxygenase in the development of gastric erosions after curing Helicobacter pylori infection.
    Miyake K; Tatsuguchi A; Suzuki K; Ueki N; Shinji Y; Kusunoki M; Iizumi T; Hiratsuka T; Nishigaki H; Futagami S; Wada K; Tsukui T; Sakamoto C
    Dig Liver Dis; 2005 Jun; 37(6):394-401. PubMed ID: 15893277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy of Campylobacter pylori infection].
    Börsch G
    Leber Magen Darm; 1988 Feb; 18(1):38-45. PubMed ID: 3280932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.